Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at Retrophin

Zippia score 3.8

Overview

JobsSalaryRevenueReviewsCEO & Executives

Retrophin overview

Industry
Biotechnology
Revenue
$198.3M
Headquarters
San Diego, CA
Employees
262
Founded in
Website
Organization type
Public
CEO
Stephen J. Aselage
Social media
Retrophin is a pharmaceutical company focused on the discovery and development of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently no viable patient options. The Company is currently focused on several catastrophic diseases affecting children, including Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and others. Retrophin's lead compound, RE-021, is scheduled to begin enrollment in a potentially pivotal Phase 2 clinical trial for FSGS during 2013.
Retrophin is a medium health care company with 262 employees and an annual revenue of $198.3M that is headquartered in San Diego, CA.

Retrophin's mission statement

To identify, develop and deliver life-changing therapies to people living with rare disease.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Retrophin employee reviews

Be the first to review!

Do you work at Retrophin?

Help job seekers learn about working at Retrophin

Job openings at Retrophin
6 positions
See all jobs

On this page

Be the first to review Retrophin

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Retrophin?

The team at Retrophin

  • The key people at Retrophin is Stephen J. Aselage.
Key people
Stephen J. Aselage
The inside scoop
Retrophin has made it their mission to identify, develop, and deliver life-changing therapies to people living with rare diseases. It aims to become a preeminent, global, and fully-integrated biopharmaceutical company within the rare disease community that is dedicated to giving patients a chance and providing hope. Their main goal is to ensure that patients have an opportunity to achieve the best possible therapeutic outcome. Retrophin strives to meet their patients' unique needs by investing in broader access to their medication.

Retrophin salaries

Average Retrophin salary
$101,141
yearly
$48.63 hourly
Updated March 14, 2024

Rate the Retrophin's inclusivity.

Zippia waving zebra

Do you work at Retrophin?

Did Retrophin's compensation package meet your expectations?

Retrophin financial performance

10.0
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Retrophin currently has 212.0M in revenue. Retrophin's most recent quarter produced 59.7m (q2'2023).

Retrophin annual revenue

$198M
$159M
$119M
$79M
$40M
$0
2015
2016
2017
2018
2019
2020

Are you an executive, HR leader, or brand manager at Retrophin?

Claiming and updating your company profile on Zippia is free and easy.

Retrophin FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Most common locations at Retrophin

Cities with Retrophin jobs

Related companies

Related company jobs

Related company salaries

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of Retrophin, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Retrophin. The employee data is based on information from people who have self-reported their past or current employments at Retrophin. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Retrophin. The data presented on this page does not represent the view of Retrophin and its employees or that of Zippia.

    Retrophin may also be known as or be related to RETROPHIN INC, Retrophin, Retrophin Inc, Retrophin, Inc. and Travere Therapeutics Inc.